⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

April 1, 1974American Journal of Clinical Pathology

Serum Copper Levels and Diphenylhydantoin

Joan Taylor P. M. Krahn Trefor Higgins

View at Publisher

Ask AI

Bookmark

Share

Abstract

J. D. Taylor, Ph.D., P. M. Krahn, Ph.D., T. N. Higgins, M.Sc.; Serum Copper Levels and Diphenylhydantoin, American Journal of Clinical Pathology, Volume 61

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Taylor et al. (1974) studied this question.

synapsesocial.com/papers/6a986a6a36e292f3f8ada25a https://doi.org/10.1093/ajcp/61.4.577

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1BRAF V600E–mutated marginal zone lymphoma may exhibit features that partially overlap with hairy cell leukemiaAmerican Journal of Clinical Pathology · Sat,
2Preanalytical variables in surgical pathology: practical sources of diagnostic error before microscopic interpretationAmerican Journal of Clinical Pathology · Fri,
3Risk factors for lymph node metastasis in a contemporary radical prostatectomy cohortAmerican Journal of Clinical Pathology · Sat,
4How I diagnose Erdheim-Chester diseaseAmerican Journal of Clinical Pathology · Sat,
5Optimizing diagnostic utility for diagnosis and management of Helicobacter pylori infections through combined microbiology and pathology approaches: a 7-year studyAmerican Journal of Clinical Pathology · Tue,

More from American Journal of Clinical Pathology

Single-cohort next-generation sequencing analysis of 713 anaplastic thyroid carcinomas: unreported gene alterations and actionable targetsMon,
Evaluation of a virulence gene repertoire as a means to investigate the role in the causal pathway to death of Escherichia coli isolated from postmortem specimens, northern TanzaniaThu,
Measurement of hemolysis in packed red blood cell segments and units using H indexWed,
Optical genome mapping refines diagnosis of high-grade myeloid neoplasms through detection of MECOM rearrangements cryptic to conventional karyotypeFri,
The essentials—measurable residual disease in hematopoietic neoplasms: current testing landscape and future directionsWed,